Who is leading CDC after Erica Schwartz?

CDC leadership shakeup in the works

Multiple reports say the White House is preparing to appoint Dr. Erica Schwartz, a deputy U.S. surgeon general during the Trump administration’s first term, as the next director of the Centers for Disease Control and Prevention.

What’s been reported so far is the selection process, not a final confirmation: current and former officials described Schwartz as the top pick coming out of HHS-level consideration. That matters because the CDC director role influences public health priorities and, critically, the agency’s approach to vaccine policy, outbreak response, and how CDC’s advisory structures interact with the administration.

The move also comes amid broader controversy around CDC vaccine recommendations and the rules governing CDC’s vaccine advisory panel. Separate coverage indicates that uncertainty has grown after vaccine guidance was altered and that the administration has been updating the framework for an expert panel that informs vaccine strategy.

In practical terms, a new CDC director could affect:

• How quickly the CDC updates vaccine recommendations during emerging outbreaks.
• How CDC coordinates with federal partners on public health messaging.
• The balance between scientific evidence and political direction in vaccine-related decisions.

While Schwartz’s name has emerged as the leading contender, the available stories don’t provide details on timing, final approval, or how her leadership would change specific programs. The key takeaway for readers is that CDC leadership is in flux, and with vaccine guidance already disrupted, the next director’s stance could shape what clinicians and the public see next.